Literature DB >> 10674100

Treatment outcome of patients with smear-negative and smear-positive pulmonary tuberculosis in the National Tuberculosis Control Programme, Malawi.

A D Harries1, T E Nyirenda, A Banerjee, M J Boeree, F M Salaniponi.   

Abstract

National tuberculosis control programmes (NTPs) in sub-Saharan Africa do not routinely record or report treatment outcome data on smear-negative pulmonary tuberculosis (PTB) patients. Twelve-month treatment outcome on patients with smear-negative PTB registered in all district and mission hospitals in Malawi during the year 1995 was collected, and was compared with 8-month treatment outcome in smear-positive PTB patients registered during the same period. Of 4240 patients with smear-negative PTB, 35% completed treatment, 25% died, 9% defaulted and 7% were transferred to another district with no treatment outcome results available. In 24% of patients treatment cards were lost and treatment outcome was unknown. These results were significantly inferior to those obtained in 4003 patients with smear-positive PTB in whom 72% completed treatment, 20% died, 4% defaulted, 2% were transferred and 1% had positive smears at the end of treatment. These differences between patients with smear-negative and smear-positive PTB were similar when analysed by sex and by most age-groups. Higher mortality rates in patients with smear-negative PTB are probably attributable to advanced HIV-related immunosuppression, and higher default and treatment unknown rates probably reflect the lack of attention paid by TB programme staff to this group of patients. As a result of this country-wide study the Malawi NTP has started to record routinely the treatment outcomes of smear-negative TB patients and has set treatment completion targets of 50% or higher for this group of patients.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10674100     DOI: 10.1016/s0035-9203(99)90153-0

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  17 in total

1.  Sputum induction to aid diagnosis of smear-negative or sputum-scarce tuberculosis in adults in HIV-endemic settings.

Authors:  Jonathan G Peter; Grant Theron; Nevanda Singh; Avani Singh; Keertan Dheda
Journal:  Eur Respir J       Date:  2013-03-21       Impact factor: 16.671

2.  Diagnostic and Treatment Monitoring Potential of A Stool-Based Quantitative Polymerase Chain Reaction Assay for Pulmonary Tuberculosis.

Authors:  Andrew R DiNardo; Alexander W Kay; Gugu Maphalala; Nadine M Harris; Celia Fung; Godwin Mtetwa; Pilar Ustero; Sindisiwe Dlamini; Ngan Ha; Edward A Graviss; Rojelio Mejia; Anna M Mandalakas
Journal:  Am J Trop Med Hyg       Date:  2018-04-19       Impact factor: 2.345

3.  Clinical indicators of mycobacteraemia in adults admitted to hospital in Blantyre.

Authors:  D K Lewis; Rph Peters; M J Schijffelen; Grf Joaki; A L Walsh; J G Kublin; J Kumwenda; S Kampondeni; M E Molyneux; E E Zijlstra
Journal:  Malawi Med J       Date:  2003-06       Impact factor: 0.875

4.  Treatment outcome of smear-positive pulmonary tuberculosis patients in Tigray Region, Northern Ethiopia.

Authors:  Gebretsadik Berhe; Fikre Enquselassie; Abraham Aseffa
Journal:  BMC Public Health       Date:  2012-07-23       Impact factor: 3.295

5.  Operational research in Malawi: making a difference with cotrimoxazole preventive therapy in patients with tuberculosis and HIV.

Authors:  Anthony D Harries; Rony Zachariah; Rhehab Chimzizi; Felix Salaniponi; Francis Gausi; Henry Kanyerere; Erik J Schouten; Andreas Jahn; Simon D Makombe; Frank M Chimbwandira; James Mpunga
Journal:  BMC Public Health       Date:  2011-07-27       Impact factor: 3.295

6.  Tuberculosis-related deaths within a well-functioning DOTS control program.

Authors:  Maria De Lourdes García-García; Alfredo Ponce-De-León; Maria Cecilia García-Sancho; Leticia Ferreyra-Reyes; Manuel Palacios-Martínez; Javier Fuentes; Midori Kato-Maeda; Miriam Bobadilla; Peter Small; José Sifuentes-Osornio
Journal:  Emerg Infect Dis       Date:  2002-11       Impact factor: 6.883

7.  Survival among patients with HIV infection and smear-negative pulmonary tuberculosis - United States, 1993-2006.

Authors:  J Sean Cavanaugh; N Sarita Shah; Kevin P Cain; Carla A Winston
Journal:  PLoS One       Date:  2012-10-23       Impact factor: 3.240

8.  The interface between the national tuberculosis control programme and district hospitals in Cameroon: missed opportunities for strengthening the local health system -a multiple case study.

Authors:  Basile Keugoung; Jean Macq; Anne Buve; Jean Meli; Bart Criel
Journal:  BMC Public Health       Date:  2013-03-22       Impact factor: 3.295

9.  Optimizing Mycobacterial Culture in Smear-Negative, Human Immunodeficiency Virus-Infected Tuberculosis Cases.

Authors:  N A Ismail; H M Said; Z Pinini; S V Omar; N Beyers; P Naidoo
Journal:  PLoS One       Date:  2015-11-06       Impact factor: 3.240

10.  Cost-effectiveness of point-of-care digital chest-x-ray in HIV patients with pulmonary mycobacterial infections in Nigeria.

Authors:  Gambo Aliyu; Samer S El-Kamary; Alash'le Abimiku; Laura Hungerford; Joshua Obasanya; William Blattner
Journal:  BMC Infect Dis       Date:  2014-12-13       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.